Green tea extract reverses endothelial dysfunction and reduces atherosclerosis progression in homozygous knockout low-density lipoprotein receptor mice

Nutrition Research

Volumn 32, Issue 9, 2012, Pages 684-693

  Minatti, Jaqueline ^a   Wazlawik, Elisabeth ^a   Hort, Mariana A ^a   Zaleski, Fernanda L ^a   Ribeiro do Valle, Rosa M ^a   Maraschin, Marcelo ^a   Da Silva, Edson L ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Atherosclerosis; Camellia sinensis; Endothelial dysfunction; Green tea extract; LDLr mice

Indexed keywords

ALANINE AMINOTRANSFERASE; CHOLESTEROL; GREEN TEA EXTRACT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CONTROLLED STUDY; DOSE RESPONSE; ENDOTHELIAL DYSFUNCTION; FEEDING; FEMALE; FOOD INTAKE; HOMOZYGOSITY; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; VASODILATATION;

ALANINE TRANSAMINASE; ANIMALS; ANTIOXIDANTS; AORTA; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; CATECHIN; CHEMOKINE CCL2; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FEMALE; INFLAMMATION; LIPOPROTEINS, LDL; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLANT EXTRACTS; RECEPTORS, LDL; TEA; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; CAMELLIA SINENSIS; MUS;

EID: 84867854568     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.08.003     Document Type: Article

References (45)

1. Babu P.V., Liu D. Green tea catechins and cardiovascular health: an update. Curr Med Chem 2008, 15:1840-1850.
2. Kuriyama S. The relation between green tea consumption and cardiovascular disease as evidenced by epidemiological studies. J Nutr 2008, 138:1548S-1553S.
3. World Health Organization Prevention of cardiovascular disease: guidelines for assessment and management of total cardiovascular risk 2007, WHO Press, Geneva.
4. Libby P., Okamoto Y., Rocha V.Z., Folco E. Inflammation in atherosclerosis: transition from theory to practice. Circ J 2010, 74(2):213-220.
5. Freestone B., Krishnamoorthy S., Lip G.Y. Assessment of endothelial dysfunction. Expert Rev Cardiovasc Ther 2010, 8:557-571.
6. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006, 86:515-581.
7. Erba D., Riso P., Bordoni A., Foti P., Biagi P.L., Testolin G. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr Biochem 2005, 16:144-149.
8. Panza V.S., Wazlawik E., Schütz R.G., Comin L., Hecht K.C., Silva E.L. Consumption of green tea favorably affects oxidative stress markers in weight-trained men. Nutrition 2008, 24:433-442.
9. Ramesh E., Geraldine P., Thomas P.A. Regulatory effect of epigallocatechingallate on the expression of C-reactive protein and other inflammatory markers in an experimental model of atherosclerosis. Chem Biol Interact 2010, 183:125-132.
10. Son D.J., Cho M.R., Jin Y.R., Kim S.Y., Park Y.H., Lee S.H., et al. Antiplatelet effect of green tea catechins: a possible mechanism through arachidonic acid pathway. Prostaglandins Leukot Essent Fatty Acids 2004, 71:25-31.
11. Antonello M., Montemurro D., Bolognesi M., Di Pascoli M., Piva A., Grego F., et al. Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts. Am J Hypertens 2007, 20:1321-1328.
12. Jochmann N., Lorenz M., Krosigk A., Martus P., Böhm V., Baumann G., et al. The efficacy of black tea in ameliorating endothelial function is equivalent to that of green tea. Br J Nutr 2008, 99:863-868.
13. Duffy S.J., Keaney J.F., Holbrook M., Gokce N., Swerdloff P.L., Frei B., et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001, 104:151-156.
14. Ishibashi S., Brown M.S., Goldstein J.L., Gerard R.D., Hammer R.E., Herz J. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993, 92:883-893.
15. Morais E.C., Stefanuto A., Klein G.A., Boaventura B.C., Andrade F., Wazlawik E., et al. Consumption of yerba mate (Ilex paraguariensis) improves serum lipid parameters in healthy dyslipidemic subjects and provides an additional LDL-cholesterol reduction in individuals on statin therapy. J Agric Food Chem 2009, 57:8316-8324.
16. Aman R., Carle R., Conrad J., Beifuss U., Schieber A. Isolation of carotenoids from plant materials and dietary supplements by high-speed counter-current chromatography. J Chromatogr A 2005, 1074:99-105.
17. Britton G. UV/visible spectroscopy. Carotenoids 1982, Vol. 1B:13-62. Birkhäuser Verlag, Basel, Switzerland.
18. Merkel M., Velez-Carrasco W., Hudgins L.C., Breslow J.L. Compared with saturated fatty acids, dietary monounsaturated fatty acids and carbohydrates increase atherosclerosis and VLDL cholesterol levels in LDL receptor-deficient, but not apolipoprotein E-deficient, mice. Proc Natl Acad Sci U S A 2001, 98(23):13294-13299.
19. Reeves P.G., Nielsen F.H., Fahey G.C. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 1993, 123(11):1939-1951.
20. Miura Y., Chiba T., Tomita I., Koizumi H., Miura S., Umegaki K., et al. Tea catechins prevent the development of atherosclerosis in apoprotein E-deficient mice. J Nutr 2001, 131:27-32.
21. Donovan J., Brown P. Blood collection. Curr Protoc Immunol 2006, 73:171-179.
22. Carvalho T.H.F., Lopes O.U. The use of genetic modified mice as a model to study cardiovascular diseases. X Simpósio Brasileiro de Fisiologia Cardiovascular, Ribeirão Preto-SP, Brazil 2006, Vol. 39:110-116.
23. Dorfman S.E., Wang S., Vega-López S., Jauhiainen M., Lichtenstein A.H. Dietary fatty acids and cholesterol differentially modulate HDL cholesterol metabolism in Golden-Syrian hamsters. J Nutr 2005, 135(3):492-498.
24. Hort M.A., Straliotto M.R., Netto P.M., da Rocha J.B., de Bem A.F., Ribeiro-do-Valle R.M. Diphenyldiselenide effectively reduces atherosclerotic lesions in LDLr -/- mice by attenuation of oxidative stress and inflammation. J Cardiovasc Pharmacol 2011, 58(1):91-101.
25. Paigen B., Morrow A., Holmes P.A., Mitchell D., Williams R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987, 68(3):231-240.
26. Rubin E.M., Krauss R.M., Spangler E.A., Verstuyft J.G., Clift S.M. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature 1991, 353(6341):265-267.
27. Cyrus T., Yao Y., Tung L.X., Praticò D. Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin. Atherosclerosis 2006, 184(1):8-14.
28. Sokal R.R., Rohlf F.J. Biometry: the principles and practice of statistics in biological research 1995, W.H. Freeman, New York.
29. Potenza M.A., Marasciulo F.L., Tarquinio M., Tiravanti E., Colantuono G., Federici A., et al. EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR. Am J Physiol Endocrinol Metab 2007, 292(5):E1378-E1387.
30. Roghani M., Baluchnejadmojarad T. Chronic epigallocatechin-gallate improves aortic reactivity of diabetic rats: underlying mechanisms. Vascul Pharmacol 2009, 51(2-3):84-89.
31. Tinahones F.J., Rubio M.A., Garrido-Sánchez L., Ruiz C., Gordillo E., Cabrerizo L., et al. Green tea reduces LDL oxidability and improves vascular function. J Am Coll Nutr 2008, 27(2):209-213.
32. Alexopoulos N., Vlachopoulos C., Aznaouridis K., Baou K., Vasiliadou C., Pietri P., et al. The acute effect of green tea consumption on endothelial function in healthy individuals. Eur J Cardiovasc Prev Rehabil 2008, 15(3):300-305.
33. Suzuki J., Ogawa M., Izawa A., Sagesaka Y.M., Isobe M. Dietary consumption of green tea catechins attenuate hyperlipidaemia-induced atherosclerosis and systemic organ damage in mice. Acta Cardiol 2005, 60(3):271-276.
34. Auclair S., Milenkovic D., Besson C., Chauvet S., Gueux E., Morand C., et al. Catechin reduces atherosclerotic lesion development in apo E-deficient mice: a transcriptomic study. Atherosclerosis 2009, 204(2):e21-e27.
35. Cao G., Sofic E., Prior R.L. Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships. Free Radic Biol Med 1997, 22(5):749-760.
36. Lankin V.Z., Tikhaze A.K., Konovalova G.G., Kozachenko A.I. Concentration inversion of the antioxidant and pro-oxidant effects of beta-carotene in tissues in vivo. Bull Exp Biol Med 1999, 128(9):314-316.
37. Forester S.C., Lambert J.D. The role of antioxidant versus pro-oxidant effects of green tea polyphenols in cancer prevention. Mol Nutr Food Res 2011, 55(6):844-854.
38. Ishii T., Mori T., Tanaka T., Mizuno D., Yamaji R., Kumazawa S., et al. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation. Free Radic Biol Med 2008, 45(10):1384-1394.
39. Stalmach A., Troufflard S., Serafini M., Crozier A. Absorption, metabolism and excretion of Choladi green tea flavan-3-ols by humans. Mol Nutr Food Res 2009, 53:S44-S53.
40. Bose M., Lambert J.D., Ju J., Reuhl K.R., Shapses S.A., Yang C.S. The major green tea polyphenol, (-)-epigallocatechin-3-gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice. J Nutr 2008, 138(9):1677-1683.
41. Hong M.H., Kim M.H., Chang H.J., Kim N.H., Shin B.A., Ahn B.W., et al. (-)-Epigallocatechin-3-gallate inhibits monocyte chemotactic protein-1 expression in endothelial cells via blocking NF-kappaB signaling. Life Sci 2007, 80(21):1957-1965.
42. Melgarejo E., Medina M.A., Sánchez-Jiménez F., Urdiales J.L. Epigallocatechingallate reduces human monocyte mobility and adhesion in vitro. Br J Pharmacol 2009, 158(7):1705-1712.
43. Isbrucker R.A., Edwards J.A., Wolz E., Davidovich A., Bausch J. Safety studies on epigallocatechingallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food Chem Toxicol 2006, 44(5):636-650.
44. Bursill C.A., Abbey M., Roach P.D. A green tea extract lowers plasma cholesterol by inhibiting cholesterol synthesis and upregulating the LDL receptor in the cholesterol-fed rabbit. Atherosclerosis 2007, 193(1):86-93.
45. Sasazuki S., Kodama H., Yoshimasu K., Liu Y., Washio M., Tanaka K., et al. Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 2000, 10(2):401-408.